TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
SVRA

Savara Inc

Healthcare · Biotechnology

5.00$ -5.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Savara Inc (SVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 253 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SVRA
Line item 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
15 0.3 0.1 4.3 14 24 53 35 11 9.0 28 62 47 55 71 54 29 160 152 136 98 177 140 178 213 253
1.6 0.2 0.1 4.3 13 23 52 34 10 9.0 28 51 37 46 58 42 15 98 113 124 85 165 129 166 202 242
1.5 0.2 0.1 4.2 13 15 26 15 9.8 8.7 28 44 23 26 36 23 13 22 24 50 23 34 52 27 15 33
1.5 0.2 0.1 4.2 13 23 52 33 9.8 8.7 28 51 37 44 57 41 13 94 111 122 82 161 126 162 196 236
– 0.0 – – – – 0.1 0.1 0.1 0.0 0.0 0.0 0.0 – – – 0.9 1.0 1.7 1.6 1.7 1.1 1.0 1.0 1.0 1.3
– – – – – – – – – – – -0.8 0.0 0.0 0.0 0.0 0.3 2.5 – -1.6 -1.7 -1.1 2.1 0.0 – –
– – – – – – – – – – – 0.5 0.2 0.1 0.2 0.2 0.1 0.9 0.5 0.4 0.2 0.3 – – – –
13 – – – – – – – – – – 3.0 3.0 3.0 3.0 3.0 3.1 27 27 0.0 – – – – – –
– – – – – – – – – – – 0.0 6.5 6.5 8.5 8.5 10 34 11 11 12 11 11 11 10 12
0.3 0.9 1.0 0.2 1.2 31 33 3.5 4.7 2.4 1.8 5.1 5.2 7.4 12 30 65 40 152 35 33 32 32 37 41 50
0.3 0.9 0.9 0.2 1.2 31 33 3.5 4.7 2.4 1.8 2.5 2.6 4.8 8.4 23 3.5 6.0 7.3 11 8.2 15 5.9 11 15 20
– 0.1 0.2 – – – – – – – – – – – – 11 0.4 0.3 0.0 2.4 0.2 8.5 0.1 0.1 0.1 0.0
0.1 0.4 0.6 0.1 0.5 0.6 0.5 0.6 1.7 0.4 0.5 0.5 0.7 1.0 1.4 2.6 0.5 2.8 3.9 3.4 2.6 1.4 1.3 3.5 4.5 5.8
– – – – – – – – – – – 0.0 0.0 0.0 0.0 3.7 2.3 15 25 23 25 17 26 26 27 30
15 -0.6 -0.9 4.1 12 -7.8 20 31 6.0 6.7 27 57 42 48 59 24 -36 119 108 102 64 144 108 140 171 203
-7.7 -24 -26 -28 -35 -60 -89 -99 -126 -142 -156 -169 -185 -206 -235 -275 -38 -68 -130 -208 -258 -301 -339 -393 -489 -608
48 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.7 1.1 1.7 2.3 3.3 18 33 40 59 134 153 165 198 222

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?